Medical Program-Wide Activities

Abstract

The Army Medical Command receives funding for research infrastructure management support at select continental United States and outside the continental US laboratories and clinical trial sites; work is done in collaboration with DoD Military Treatment Facilities. This program element does not fund research. It funds the infrastructure support staff enabling research scientists to conduct bio-surveillance and early-to-late-stage clinical investigations into biologics, drugs, protectants, device technologies, and knowledge products. The funding provides for the sustainment of technical subject matter expertise, independent of the number of assigned projects, and the costs related to the initial outfitting and transition (IO&T) of research, development, test, and evaluation medical laboratories funded under multi-year military construction (MILCON) projects. These IO&T funds are designated as appropriations other than MILCON. The Office of the Assistant Secretary of Defense for Health Affairs (Force Health Protection & Readiness) receives funds to provide management support for research projects at Pacific Joint Information Technology Center (P-JITC). For the Navy Bureau of Medicine and Surgery, this program element includes facility operational funding for the Medical Biological Defense research sub-function of the Naval Medical Research Center (NMRC) Biological Defense Research Directorate (BDRD). The program mission is mandated by the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense (JRO-CBRND) baseline capabilities assessment of chemical and biological passive defense. The primary function is research on countermeasures to biological threat agents, development of assays to detect biological threat agents, and bioforensic analysis of biological threat agents.

Document Details

• Document Type: R2 Budgetary Justification
• Publication Date: Oct 01, 2018
• Source ID: 0606105DHA_2_0130_PB_2018
• Change Summary Explanation: FY 2016: Congressional Special Interest (CSI) Additions to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (+$16.240 million). FY 2016: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0606105-Medical Program-Wide Activities (-$4.502 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) Program (+$4.502 million). FY 2017: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), Program Element (PE) 0603115-Medical Technology Development (-$38.211 million) to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (+$38.211 million). FY 2017: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), Program Element (PE) PE 0606105-Medical Program-Wide Activities (-$5.191 million) to DHP O&M, BAG 3 - Private Sector Care (+$5.191 million). FY 2017: Pike's Peak Investment, PE 0606105-Medical Program-Wide Activities (+$0.234 million).
• Service Agency Name: Defense Health Agency

Entities

Organizations

• Defense Health Agency

Tags

DTIC Thesaurus Topics

• Acquisition
• Biomedical Research
• Civilian Personnel
• Clinical Trials
• Combat Casualty Care
• Dengue
• Diseases And Disorders
• Infectious Diseases
• Information Systems
• Infrastructure
• Medical Laboratories
• Medical Personnel
• Military Medicine
• Military Research
• Personnel Management
• Test And Evaluation
• United States

Readers

• Critical Infrastructure Protection in CBRN and WMD Threats.
• Medical or Health Care Field.